Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Myojin

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Hepatology (Baltimore, Md.)|January 15, 2026
NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinomaShuhei Yamamoto, Takahiro Kodama, Akifumi Kuwano, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
The Gut Microbiome Controls Liver Tumors via the Vagus NerveKylynda C Bauer, Rajiv Trehan, Benjamin Ruf, et al.
Immunity|March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TMEMohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 18, 2025
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus EliminationYuta Myojin, Hayato Hikita, Yuki Tahata, et al.
Gut|February 18, 2025
Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumabYuta Myojin, Sepideh Babaei, Rajiv Trehan, et al.
Cell|August 18, 2023
Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive marginBenjamin Ruf, Matthias Bruhns, Sepideh Babaei, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Hepatology (Baltimore, Md.)|January 15, 2026
NRF2-COX2-PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinomaShuhei Yamamoto, Takahiro Kodama, Akifumi Kuwano, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
The Gut Microbiome Controls Liver Tumors via the Vagus NerveKylynda C Bauer, Rajiv Trehan, Benjamin Ruf, et al.
Immunity|March 15, 2025
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TMEMohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 18, 2025
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus EliminationYuta Myojin, Hayato Hikita, Yuki Tahata, et al.
Gut|February 18, 2025
Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumabYuta Myojin, Sepideh Babaei, Rajiv Trehan, et al.
Cell|August 18, 2023
Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive marginBenjamin Ruf, Matthias Bruhns, Sepideh Babaei, et al.
Pageof 4